Advertisement

Topics

Polyganics Company Profile

09:30 EDT 14th August 2018 | BioPortfolio

Polyganics is a medical technology company with multiple versatile polymer platforms. The Company develops, manufactures and commercializes innovative bioresorbable medical devices that facilitate tissue repair and regeneration.


News Articles [6 Associated News Articles listed on BioPortfolio]

FDA Says Dutch Biotech’s Surgical Sealant Patch Could Save Lives

Polyganics, based in Groningen, has received a Breakthrough Device Designation from the FDA for its sealant patch for surgical wounds.  Polyganics specializes in medical devices that use natural pol...

FDA Grants Breakthrough Device Designation to Polyganics’ Liver and Pancreas Sealant Patch.

Groningen, The Netherlands – 8 March 2017 – Polyganics, a privately held medical technology company that develops, manufactures and commercializes bioresorbable medical devices, today an...

FDA Grants Breakthrough Device Designation to Polyganics’ Liver and Pancreas Sealant Patch

Polyganics, a privately held medical technology company that develops, manufactures and commercializes bioresorbable medical devices, today announced that the US Food and Drug Adm...

20152023 World Nerve Repair Biomateria Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 01072017] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and en...

Global and China Nerve Repair Biomateria Market Research by Company, Type Application 20132025 [Report Updated: 09032018] Prices from USD $2000

SummaryMarket Segment as follows:By Type Laboratory Grade Industrial GradeBy Application Repair Transplant OthersBy Company Axogen Integra Synovis Collagen Matrix Polygan...

Global Nerve Repair Biomateria Market Analysis 20122017 and Forecast 20182023 [Report Updated: 19012018] Prices from USD $2980

SummaryThe global Nerve Repair Biomateria market will reach xxx Million USD in 2017 and CAGR xx% 20112017. The report begins from overview of Industry Chain structure, and describes industry environme...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma

This post-market surveillance study is conducted to provide post market surveillance information regarding long-term performance and ease of use of the Polyganics nerve capping device (NEU...

Surgical Treatment of Symptomatic Neuroma

This study is conducted to clinically assess safety and performance of the Polyganics nerve capping device for the treatment of symptomatic neuroma. There is sufficient clinical experience...

Companies [1 Associated Companies listed on BioPortfolio]

Polyganics

Polyganics is a medical technology company with multiple versatile polymer platforms. The Company develops, manufactures and commercializes innovative bioresorbable medical device...

More Information about "Polyganics" on BioPortfolio

We have published hundreds of Polyganics news stories on BioPortfolio along with dozens of Polyganics Clinical Trials and PubMed Articles about Polyganics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Polyganics Companies in our database. You can also find out about relevant Polyganics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record